You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 149 No. 2, February 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Use of a Sensitive Thyrotropin Assay for Monitoring Treatment With Levothyroxine

Nelson B. Watts, MD

Arch Intern Med. 1989;149(2):309-312.


Abstract

• To determine if a sensitive assay for thyrotropin (thyroid-stimulating hormone [TSH]) would be useful as a primary test to determine optimal doses of levothyroxine, an enzyme immunoassay for TSH that discriminated hyperthyroid from euthyroid subjects with no overlap was compared with radioimmunoassays for TSH and thyroxine (T4) and the calculated free thyroxine index (FTI) in 100 patients receiving stable doses of levothyroxine. The basal TSH level, determined with the sensitive assay, predicted the TSH response to thy rotropinreleasing hormone (TRH); all patients whose basal TSH level was less than 0.35 mU/L had absent or subnormal responses, and all patients with TSH levels of 0.35 mU/L or greater had normal responses. In patients with normal TSH levels, the T4 level and FTI were superfluous (normal) or misleadingly high; conversely, 65% of patients with low TSH levels had normal T4 levels or FTIs, or both. An assay for TSH with sufficient sensitivity to discriminate between abnormally low values and the low range of normal can be used as the primary test for monitoring levothyroxine treatment. The T4 or FTI measurements are not needed if the TSH level is normal, but they should be done in patients with low TSH levels.

(Arch Intern Med 1989;149:309-312)



Author Affiliations

From the Department of Medicine (Endocrinology), Emory University School of Medicine, Atlanta.


Footnotes

Accepted for publication March 2, 1988.

Presented in part at the 62nd Annual Meeting of the American Thyroid Association, Washington, DC, Sept 16, 1987.

Reprint requests to The Emory Clinic, 1365 Clifton Rd NE, Atlanta, GA 30322 (Dr Watts).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Thyroid Hormone, Osteoporosis, and Estrogen
Cooper
JAMA 1994;271:1283-1284.
ABSTRACT  

Monitoring Therapy in Patients Taking Levothyroxine
Helfand and Crapo
ANN INTERN MED 1990;113:450-454.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.